Analysts' ratings for PACS Group PACS over the last quarter vary from bullish to bearish, as provided by 7 analysts.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 3 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 2 | 2 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 1 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $40.14, a high estimate of $45.00, and a low estimate of $35.00. This upward trend is apparent, with the current average reflecting a 17.37% increase from the previous average price target of $34.20.
Diving into Analyst Ratings: An In-Depth Exploration
The standing of PACS Group among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Jason Cassorla | Citigroup | Announces | Buy | $45.00 | - |
| David Macdonald | Truist Securities | Raises | Buy | $44.00 | $36.00 |
| Scott Fidel | Stephens & Co. | Raises | Overweight | $40.00 | $37.00 |
| Jason Cassorla | Citigroup | Raises | Buy | $41.00 | $34.00 |
| Michael Wiederhorn | Oppenheimer | Raises | Outperform | $40.00 | $32.00 |
| David Macdonald | Truist Securities | Raises | Buy | $36.00 | $32.00 |
| Tao Qiu | Macquarie | Announces | Outperform | $35.00 | - |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to PACS Group. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of PACS Group compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of PACS Group's stock. This analysis reveals shifts in analysts' expectations over time.
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of PACS Group's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on PACS Group analyst ratings.
Get to Know PACS Group Better
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.
Unraveling the Financial Story of PACS Group
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: PACS Group's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 29.08%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: PACS Group's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -1.11%, the company may face hurdles in effective cost management.
Return on Equity (ROE): PACS Group's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -3.12%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): PACS Group's ROA excels beyond industry benchmarks, reaching -0.28%. This signifies efficient management of assets and strong financial health.
Debt Management: PACS Group's debt-to-equity ratio stands notably higher than the industry average, reaching 4.67. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
The Significance of Analyst Ratings Explained
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
